Leonardo Mancillas-Adame
Overview
Explore the profile of Leonardo Mancillas-Adame including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chavez-Manzanera E, Vera-Zertuche J, Kaufer-Horwitz M, Vazquez-Velazquez V, Flores-Lazaro J, Mireles-Zavala L, et al.
Curr Obes Rep
. 2024 Oct;
13(4):643-666.
PMID: 39356455
Purpose: To develop Mexico's first methodologically rigorous clinical practice guideline for the management of adult overweight and obesity. The target audiences are interdisciplinary healthcare professionals across healthcare systems who are...
2.
Unnikrishnan A, Viswanathan V, Zhou F, Hao L, Kamath P, Bertolini M, et al.
Diabetes Ther
. 2022 Mar;
13(5):983-993.
PMID: 35316509
Introduction: My Dose Coach (MDC) is a US Food and Drug Administration-approved digital smartphone application designed to help users with type 2 diabetes (T2D) titrate their basal insulin (BI) according...
3.
Mehta R, Bello-Chavolla O, Mancillas-Adame L, Rodriguez-Flores M, Ramirez Pedraza N, Encinas B, et al.
Int J Obes (Lond)
. 2022 Jan;
46(4):866-873.
PMID: 35017712
Background: Increased adiposity and visceral obesity have been linked to adverse COVID-19 outcomes. The amount of epicardial adipose tissue (EAT) may have relevant implications given its proximity to the heart...
4.
Rodriguez-Flores M, Goicochea-Turcott E, Mancillas-Adame L, Garibay-Nieto N, Lopez-Cervantes M, Rojas-Russell M, et al.
Int J Obes (Lond)
. 2022 Jan;
46(3):661-668.
PMID: 34974543
Background: Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of the Edmonton...
5.
Vazquez-Velazquez V, Laviada-Molina H, Garcia-Garcia E, Sandoval-Diez E, Mancillas-Adame L
Obesity (Silver Spring)
. 2021 Jan;
29(2):317-326.
PMID: 33491317
Objective: The Awareness, Care, and Treatment in Obesity Management-International Observation (ACTION-IO) study (ClinicalTrials.gov identifier NCT03584191) aimed to identify perceptions, attitudes, behaviors, and barriers to effective obesity care in people with...
6.
Sanchez-Garcia A, Rodriguez-Gutierrez R, Saldivar-Rodriguez D, Guzman-Lopez A, Mancillas-Adame L, Gonzalez-Nava V, et al.
Int J Gynaecol Obstet
. 2020 Jul;
151(1):117-123.
PMID: 32679624
Objective: To assess the risk of gestational diabetes mellitus (GDM) according to the triglyceride and glucose (TyG) index values during the first trimester of pregnancy in Latin American women. Methods:...
7.
Alcocer-Gamba M, Gutierrez-Fajardo P, Sosa-Caballero A, Cabrera-Rayo A, Faradji-Hazan R, Padilla-Padilla F, et al.
Arch Cardiol Mex
. 2020 Jun;
90(Supl):77-83.
PMID: 32523151
A review is carried out to examine the risk of patients suffering from diabetes mellitus in the context of general morbidity and mortality and related to infection by SARS-CoV-2. Likewise,...
8.
Sanchez-Garcia A, Rodriguez-Gutierrez R, Mancillas-Adame L, Gonzalez-Nava V, Gonzalez-Colmenero A, Solis R, et al.
Int J Endocrinol
. 2020 Apr;
2020:4678526.
PMID: 32256572
Objective: To summarize the evidence assessing the diagnostic accuracy of the TyG index regarding IR. Methods: A comprehensive search in MEDLINE, EMBASE, Web of Science, and Scopus was performed without...
9.
Sanchez-Garcia A, Rodriguez-Gutierrez R, Saldivar-Rodriguez D, Guzman-Lopez A, Castillo-Castro C, Mancillas-Adame L, et al.
Gynecol Endocrinol
. 2020 Apr;
36(12):1112-1115.
PMID: 32233827
The oral glucose tolerance test (OGTT) remains as the gold standard to diagnose gestational diabetes mellitus (GDM); however, this test may be inconvenient and costly. Hence, other easy to perform...
10.
Pollock R, Norrbacka K, Cameron C, Mancillas-Adame L, Jeddi M
J Comp Eff Res
. 2019 Jan;
8(4):229-240.
PMID: 30644328
Aim: The prevalence of Type 2 diabetes in Canada is estimated to be 7.6% and rising. Given the substantial economic burden associated with Type 2 diabetes treatment, optimizing healthcare expenditure...